Moderna climbs for second straight session

Alpha Pro Tech

11/05/2026 16:58

Updates

** Shares of Moderna MRNA.O rise as much as 9.4% on Monday, last up marginally

** Last week, the vaccine maker told Reuters it conducted preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases

** Any vaccine will need to demonstrate success in studies likely to cost more than $500 million, funding from governments may help cover these costs - Bernstein analysts

** "We don't see this as the next 'pandemic' and think this hantavirus-related trade should fade from current
highs
," adds brokerage

** Shares of personal protective equipment makers Lakeland Industries LAKE.O rise about 2% and Alpha Pro Tech APT.A gain more than 6%

** Including session's moves, MRNA up 84.6% YTD

 (Reporting by Christy Santhosh)

 ((Christy.Santhosh@thomsonreuters.com))